Conferences
#ESHMPN2026

11th Translational Research Conference
Myeloproliferative Neoplasms

‍

#ESHMPN2026
Translational
April 24-26, 2026
-
Estoril, Portugal

Chairs: Jean-Jacques Kiladjian, Ross L. Levine, Ann Mullally, Jyoti Nangalia

11th Translational Research Conference
Myeloproliferative Neoplasms

‍

Information

‍

ABOUT THE CONFERENCE:

ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction.
Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks.

New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.

This educational conference has been approved for 14,5 CME-CPD credit points by the European Board for Accreditation in Hematology (EBAH)!

‍

‍

SCIENTIFIC TOPICS:

• Somatic evolution and MPN
• New approaches for targeting MPN
• New causes and classification
• Recent developments in blast phase MPN
• Novel functional insights downstream of JAK/CALR/MPL
• MPN management
• Disease mechanisms in MPN
• Aberrant cell populations in MPN
• New frontiers in MPN, where is the field going?

‍

Programme

Read the final programme!

CLICK HERE
ON-DEMAND CONTENT AVAILABLE
CLICK HERE

Corporate partners

With the support of*:

‍

‍Major Conference Partners
*******

‍

‍

‍Level 1 Conference Partner
*******

‍

‍

‍

‍

‍Level 2 Conference Partners
*******

‍

‍

Supporting Conference Partner
*******

‍

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

Advancing haematology through international leading-edge disease- focused conferences.

Explore a portfolio of leading-edge scientific, translational research and clinically oriented meetings, designed to foster scientific exchange, practical insight, education and collaboration across clinical and research fields.
Explore all conferences